Dorsey Wright & Associates’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-98
Closed -$14K 398
2020
Q4
$14K Buy
+98
New +$10.5K ﹤0.01% 257

Other funds holding ONCS

Dorsey Wright & Associates's ONCS Position: Q1 2021 in Review

Dorsey Wright & Associates sold out of OncoSec Medical Incorporated (ONCS) in Q1 2021, closing a stake of 98 shares — an estimated $14K sold.

Dorsey Wright & Associates first reported a position in ONCS in Q4 2020 and held it in 1 quarter. The position peaked at $14K in Q4 2020. 34 funds tracked by Wall St. Rank hold ONCS as of Q1 2021.

  • Dorsey Wright & Associates reported no remaining OncoSec Medical Incorporated position as of Q1 2021 after selling out during the quarter.
  • Dorsey Wright & Associates sold 98 OncoSec Medical Incorporated shares in Q1 2021, an estimated $14K.
  • Dorsey Wright & Associates first reported a position in OncoSec Medical Incorporated in Q4 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's OncoSec Medical Incorporated position peaked at $14K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2021.

Based on Dorsey Wright & Associates's 13F filing for Q1 2021, filed 27 Apr 2021.